Jindal Drilling & Industries Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 3, 2025, 9:04 pm

Competitors of Jindal Drilling & Industries Ltd

All Competitor Stocks of Jindal Drilling & Industries Ltd

Quarterly Result

Last Updated: August 1, 2025, 6:50 pm

Below is a detailed analysis of the quarterly data for Jindal Drilling & Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 254.00 Cr.. The value appears strong and on an upward trend. It has increased from 245.00 Cr. (Mar 2025) to 254.00 Cr., marking an increase of 9.00 Cr..
• For Expenses, as of Jun 2025, the value is 147.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 158.00 Cr. (Mar 2025) to 147.00 Cr., marking a decrease of 11.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 107.00 Cr.. The value appears strong and on an upward trend. It has increased from 87.00 Cr. (Mar 2025) to 107.00 Cr., marking an increase of 20.00 Cr..
• For OPM %, as of Jun 2025, the value is 42.00%. The value appears strong and on an upward trend. It has increased from 36.00% (Mar 2025) to 42.00%, marking an increase of 6.00%.
• For Other Income, as of Jun 2025, the value is 8.00 Cr.. The value appears to be declining and may need further review. It has decreased from 19.00 Cr. (Mar 2025) to 8.00 Cr., marking a decrease of 11.00 Cr..
• For Interest, as of Jun 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
• For Depreciation, as of Jun 2025, the value is 37.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 31.00 Cr. (Mar 2025) to 37.00 Cr., marking an increase of 6.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 76.00 Cr.. The value appears strong and on an upward trend. It has increased from 71.00 Cr. (Mar 2025) to 76.00 Cr., marking an increase of 5.00 Cr..
• For Tax %, as of Jun 2025, the value is 25.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 25.00%.
• For Net Profit, as of Jun 2025, the value is 56.00 Cr.. The value appears strong and on an upward trend. It has increased from 53.00 Cr. (Mar 2025) to 56.00 Cr., marking an increase of 3.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 19.48. The value appears strong and on an upward trend. It has increased from 18.38 (Mar 2025) to 19.48, marking an increase of 1.10.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 5:04 am

Growth

Last Updated: September 5, 2025, 8:15 am

Balance Sheet

Last Updated: August 11, 2025, 2:08 pm

Below is a detailed analysis of the balance sheet data for Jindal Drilling & Industries Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 14.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 14.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,296.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,163.00 Cr. (Mar 2024) to 1,296.00 Cr., marking an increase of 133.00 Cr..
• For Borrowings, as of Mar 2025, the value is 164.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 294.00 Cr. (Mar 2024) to 164.00 Cr., marking a decrease of 130.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 1,006.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 368.00 Cr. (Mar 2024) to 1,006.00 Cr., marking an increase of 638.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,481.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,840.00 Cr. (Mar 2024) to 2,481.00 Cr., marking an increase of 641.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 1,294.00 Cr.. The value appears strong and on an upward trend. It has increased from 551.00 Cr. (Mar 2024) to 1,294.00 Cr., marking an increase of 743.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 306.00 Cr.. The value appears strong and on an upward trend. It has increased from 243.00 Cr. (Mar 2024) to 306.00 Cr., marking an increase of 63.00 Cr..
• For Other Assets, as of Mar 2025, the value is 880.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,045.00 Cr. (Mar 2024) to 880.00 Cr., marking a decrease of 165.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,481.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,840.00 Cr. (Mar 2024) to 2,481.00 Cr., marking an increase of 641.00 Cr..

Notably, the Reserves (1,296.00 Cr.) exceed the Borrowings (164.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Jindal Drilling & Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 74.50. This value is within the healthy range. It has increased from 17.65 (Mar 24) to 74.50, marking an increase of 56.85.
• For Diluted EPS (Rs.), as of Mar 25, the value is 74.50. This value is within the healthy range. It has increased from 17.65 (Mar 24) to 74.50, marking an increase of 56.85.
• For Cash EPS (Rs.), as of Mar 25, the value is 79.35. This value is within the healthy range. It has increased from 61.32 (Mar 24) to 79.35, marking an increase of 18.03.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 548.01. It has increased from 470.03 (Mar 24) to 548.01, marking an increase of 77.98.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 548.01. It has increased from 470.03 (Mar 24) to 548.01, marking an increase of 77.98.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 285.69. It has increased from 212.90 (Mar 24) to 285.69, marking an increase of 72.79.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 101.38. This value is within the healthy range. It has increased from 78.70 (Mar 24) to 101.38, marking an increase of 22.68.
• For PBIT / Share (Rs.), as of Mar 25, the value is 70.63. This value is within the healthy range. It has increased from 56.74 (Mar 24) to 70.63, marking an increase of 13.89.
• For PBT / Share (Rs.), as of Mar 25, the value is 65.01. This value is within the healthy range. It has increased from 52.33 (Mar 24) to 65.01, marking an increase of 12.68.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 48.60. This value is within the healthy range. It has increased from 39.37 (Mar 24) to 48.60, marking an increase of 9.23.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 74.50. This value is within the healthy range. It has increased from 17.65 (Mar 24) to 74.50, marking an increase of 56.85.
• For PBDIT Margin (%), as of Mar 25, the value is 35.48. This value is within the healthy range. It has decreased from 36.96 (Mar 24) to 35.48, marking a decrease of 1.48.
• For PBIT Margin (%), as of Mar 25, the value is 24.72. This value exceeds the healthy maximum of 20. It has decreased from 26.65 (Mar 24) to 24.72, marking a decrease of 1.93.
• For PBT Margin (%), as of Mar 25, the value is 22.75. This value is within the healthy range. It has decreased from 24.57 (Mar 24) to 22.75, marking a decrease of 1.82.
• For Net Profit Margin (%), as of Mar 25, the value is 17.01. This value exceeds the healthy maximum of 10. It has decreased from 18.49 (Mar 24) to 17.01, marking a decrease of 1.48.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 26.07. This value exceeds the healthy maximum of 20. It has increased from 8.28 (Mar 24) to 26.07, marking an increase of 17.79.
• For Return on Networth / Equity (%), as of Mar 25, the value is 13.59. This value is below the healthy minimum of 15. It has increased from 3.75 (Mar 24) to 13.59, marking an increase of 9.84.
• For Return on Capital Employeed (%), as of Mar 25, the value is 10.97. This value is within the healthy range. It has increased from 9.86 (Mar 24) to 10.97, marking an increase of 1.11.
• For Return On Assets (%), as of Mar 25, the value is 7.63. This value is within the healthy range. It has increased from 2.44 (Mar 24) to 7.63, marking an increase of 5.19.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 0.2. It has decreased from 0.09 (Mar 24) to 0.04, marking a decrease of 0.05.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.10. This value is within the healthy range. It has decreased from 0.21 (Mar 24) to 0.10, marking a decrease of 0.11.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.33. It has increased from 0.30 (Mar 24) to 0.33, marking an increase of 0.03.
• For Current Ratio (X), as of Mar 25, the value is 0.98. This value is below the healthy minimum of 1.5. It has decreased from 1.65 (Mar 24) to 0.98, marking a decrease of 0.67.
• For Quick Ratio (X), as of Mar 25, the value is 0.92. This value is below the healthy minimum of 1. It has decreased from 1.56 (Mar 24) to 0.92, marking a decrease of 0.64.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 15.90. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 15.90, marking an increase of 15.90.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.67. This value is below the healthy minimum of 20. It has decreased from 2.83 (Mar 24) to 0.67, marking a decrease of 2.16.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.47. This value is below the healthy minimum of 20. It has decreased from 1.26 (Mar 24) to 0.47, marking a decrease of 0.79.
• For Earning Retention Ratio (%), as of Mar 25, the value is 99.33. This value exceeds the healthy maximum of 70. It has increased from 97.17 (Mar 24) to 99.33, marking an increase of 2.16.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 99.53. This value exceeds the healthy maximum of 70. It has increased from 98.74 (Mar 24) to 99.53, marking an increase of 0.79.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 18.06. This value is within the healthy range. It has increased from 17.81 (Mar 24) to 18.06, marking an increase of 0.25.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 9.66. This value is within the healthy range. It has decreased from 9.91 (Mar 24) to 9.66, marking a decrease of 0.25.
• For Enterprise Value (Cr.), as of Mar 25, the value is 2,480.17. It has increased from 2,029.01 (Mar 24) to 2,480.17, marking an increase of 451.16.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.00. This value is within the healthy range. It has decreased from 3.29 (Mar 24) to 3.00, marking a decrease of 0.29.
• For EV / EBITDA (X), as of Mar 25, the value is 8.44. This value is within the healthy range. It has decreased from 8.90 (Mar 24) to 8.44, marking a decrease of 0.46.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.92. This value is within the healthy range. It has decreased from 2.99 (Mar 24) to 2.92, marking a decrease of 0.07.
• For Retention Ratios (%), as of Mar 25, the value is 99.32. This value exceeds the healthy maximum of 70. It has increased from 97.16 (Mar 24) to 99.32, marking an increase of 2.16.
• For Price / BV (X), as of Mar 25, the value is 1.52. This value is within the healthy range. It has increased from 1.35 (Mar 24) to 1.52, marking an increase of 0.17.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.92. This value is within the healthy range. It has decreased from 2.99 (Mar 24) to 2.92, marking a decrease of 0.07.
• For EarningsYield, as of Mar 25, the value is 0.08. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.08, marking an increase of 0.06.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness